Cory Fulcher
Otolaryngology · Salt Lake City, UTNPI 1295238095
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 46.7% of the total.
Across 62 payments — averaging $44.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Aerin Medical Inc.$442
- Stryker$313
- GSK$263
- Regeneron Healthcare Solutions, Inc.$200
- Sanofi$61
- plus $187 from 5 others
What the payments were for
- Travel & lodging$1,18843%
- Food & beverage$1,55957%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 17 | $1,282 |
| Aerin Medical Inc. | 8 | $442 |
| Stryker | 5 | $313 |
| GSK | 15 | $263 |
| Regeneron Healthcare Solutions, Inc. | 8 | $200 |
| Sanofi | 3 | $61 |
| Pacira Pharmaceuticals Incorporated | 1 | $59 |
| Smith+Nephew | 1 | $45 |
| Optinose US, Inc. | 2 | $44 |
| AstraZeneca | 1 | $20 |
| Kaleo, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,129
- NUCALA$125
- VIVAER STYLUS$123
How this compares
$2,747 in reported general payments places this provider in the 70th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 29 | $511 |
| Ipratropium Bromide | 12 | $408 |
| Azelastine Hcl | 11 | $371 |
| Famotidine | 17 | $216 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $174 |
| Methylprednisolone | 11 | $112 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salt Lake City
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Matthew DahlSalt Lake City$12K
- Anthony SanchezSalt Lake City$7K
- Pramod SharmaSalt Lake City$5K
- Joshua BradleySalt Lake City$3K
- Allison DurhamSalt Lake City$3K
- Mitchell DunklebargerSalt Lake City$2K
- Daniel BestourousSalt Lake City$2K
- John BennettSalt Lake City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.